Transforming healthcare through precision genomics, AI-powered insights, and personalized medicine
GeneMatrix is a pioneering genomics company dedicated to making personalized medicine accessible to everyone. Through cutting-edge DNA analysis and AI-powered insights, we're transforming healthcare one genome at a time.
Since 2022, GeneMatrix has been at the forefront of precision genomics — combining AI-powered analysis, certified laboratory science, and a relentless commitment to making personalized medicine accessible worldwide.
GeneMatrix was founded in 2022 by Tarek Younis — a healthcare technology entrepreneur united by one conviction: that every person deserves access to the power of their own genetic blueprint. From our Chicago headquarters, we set out to bridge the gap between cutting-edge genomic science and real-world clinical care.
Democratizing precision medicine from day one.
In 2022, GeneMatrix opened its first fully CLIA-certified, CE-IVD Certified laboratory — a state-of-the-art facility engineered for high-throughput genomic sequencing. This milestone allowed us to scale from research to real clinical delivery, processing thousands of samples with 99.9% accuracy and industry-leading turnaround times.
99.9% accuracy. Clinical-grade from the start.
In 2024, we integrated our proprietary AI engine — trained on millions of anonymized genetic profiles — directly into our diagnostic pipeline. This leap transformed raw sequencing data into actionable, personalized health insights in real time, enabling clinicians and patients to make faster, smarter decisions backed by genomic science.
Real-time AI interpretation. Personalized at scale.
Today, GeneMatrix operates across 6 countries with a focused expansion into the European Union and Balkan Regions — bringing precision genomics to underserved healthcare markets. Our global network of certified lab partners and clinical affiliates ensures that world-class genetic testing is accessible regardless of geography.
EU & Balkans — precision medicine without borders.
Explore our genomic tests and discover what your DNA can tell you.
To democratize precision genomics by making advanced genetic testing accessible, affordable, and actionable for everyone, empowering individuals to take control of their health through personalized insights.
A world where every individual has access to their genetic blueprint, enabling proactive healthcare decisions that prevent disease, optimize wellness, and extend healthy lifespan through precision medicine.
At GeneMatrix, our values aren't just words — they're the foundation of every test, every insight, and every life we touch.
Your genetic data is protected with military-grade encryption and zero-knowledge architecture. We never share, sell, or access your data without explicit consent.
Every test is validated through peer-reviewed research and certified by our team of world-class geneticists, ensuring the highest accuracy in every result.
We place individuals at the heart of every decision — delivering actionable, personalized insights that empower proactive health management and informed choices.
Breaking down barriers to make precision genetic healthcare available and affordable to communities across the EU, Balkans, and beyond — no matter where you are.
Continuously advancing genetic testing through proprietary AI models, deep learning, and cutting-edge research — pushing the boundaries of what genomics can achieve.
Partnering with healthcare providers, research institutions, and global communities to co-create solutions that drive measurable improvements in health outcomes.
From a bold vision to a global leader in personalized genetic healthcare
GeneMatrix was founded with a vision to democratize personalized healthcare through genetic testing.
Opened our state-of-the-art genetic testing laboratory with CLIA and CAP certifications.
Launched our proprietary AI engine for advanced genetic data analysis and personalized recommendations.
Expanded operations across the EU and Balkan Regions, bringing personalized genetic healthcare to new communities.
Surpassed 10,000 genetic tests processed, helping families across 6 countries make informed health decisions.
Established our newest Fulton Labs Headquarters, a cutting-edge R&D Innovation Center focusing on next-generation genetic testing technologies.
Our experienced leadership team combines decades of industry expertise with innovative thinking to drive precision medicine forward.
Chief Executive Officer
Tarek Younis is the visionary founder and CEO of Gene Matrix AI, leading the company's mission to revolutionize healthcare through AI-powered genetic diagnostics. With over 15 years of experience in healthcare technology and biotechnology, Tarek has been instrumental in bridging the gap between advanced genomic science and accessible healthcare solutions.
Under his leadership, Gene Matrix has expanded to serve healthcare providers across multiple continents, establishing partnerships with leading hospitals, research institutions, and government health agencies. His commitment to making precision medicine accessible to all has driven the development of innovative testing solutions that are both affordable and clinically actionable.
Chief Scientific Officer
Dr. Chen leads our scientific research and development initiatives, bringing 20+ years of experience in molecular genetics and computational biology from Stanford University and leading biotech firms.
Executive Director of Business & Operations
Lammy Shaheen oversees business strategy and operational excellence at Gene Matrix AI. With extensive experience in healthcare operations and business development, she ensures seamless execution of our mission to deliver world-class genetic testing services.
President of European Operations
Saso spearheads Gene Matrix's European expansion strategy, establishing key partnerships across the EU healthcare sector. His expertise in regulatory compliance and market development has been pivotal to our growth.
Chief Medical Officer
Dr. Okonkwo ensures clinical excellence across all testing services. Board-certified in medical genetics with fellowship training at Johns Hopkins, he oversees our medical advisory board and clinical protocols.
Director of African Markets
Dr. Nkosi leads our mission to bring precision medicine to Africa. With a PhD in Public Health from Harvard and deep expertise in healthcare systems across the continent, she drives impactful partnerships.
Our clinical decisions are guided by a panel of board-certified physicians, geneticists, and researchers from leading academic medical centers — ensuring every insight meets the highest standard of evidence-based medicine.
Independent Clinical Oversight
Our advisory board operates independently — reviewing test methodologies, variant classifications, and clinical report standards on a quarterly basis.
Every certification listed here is real, verifiable, and actively maintained. No marketing fluff.
CLIA ID: 14D2197372
Issued by: Centers for Medicare & Medicaid Services (CMS)
Clinical Laboratory Improvement Amendments — the federal standard for laboratory quality and accuracy.
Verified Compliance
Issued by: U.S. Department of Health & Human Services
Full compliance with the Health Insurance Portability and Accountability Act for patient data privacy and security.
CE Mark — In Vitro Diagnostics
Issued by: European Commission
Confirms our diagnostic tests meet EU safety, quality, and performance requirements under the IVDR framework.
Accredited Laboratory
Issued by: International Organization for Standardization
International standard for medical laboratory quality and competence — the highest global benchmark for diagnostic labs.
Certifications are actively maintained and subject to periodic renewal audits.
Only verified, published articles are listed here. Each link goes directly to the original source.
NBC Chicago
2024
NBC Chicago covers how Gene Matrix is working to build trust in genetic testing among underserved communities of color in the Chicago area.
NBC Chicago
2024
NBC Chicago features Gene Matrix's Bedford Park laboratory and its mission to make precision genetic testing accessible to diverse communities.
We do not list hospital or institutional partnerships unless a formal, signed agreement is in place. The media coverage above links directly to published articles on the original news outlets.
All tests include a DNA kit, AI-powered analysis, and lifetime access to your HIPAA-secure portal. Results in 5–7 days.
Premium
HSA/FSA eligible • Cancel anytime • 5–7 day results
Join 10,000+ patients who trust GeneMatrix for precision genomic insights
We use cookies to ensure our website functions securely and to improve your experience. As a healthcare provider handling sensitive genetic data, we adhere to strict HIPAA and GDPR standards. No personal health information (PHI) is ever stored in cookies. You can customize your preferences below.
